Menu Close

Get Inspired By 21 Patient Advocacy Groups & Pharma Brands Including Pfizer, Cancer Research UK, Merck & UCB As They Tackle Your Toughest Challenges To Real Patient Centricity & Engagement!

Secure Better Patient & Business Outcomes With Actionable, Tangible, Value-Adding Strategies To Enhance Patient Centricity & Engagement & Embed Patients At The Heart Of Decision Making
Collaborative Engagement & Experience Strategies Which Inform Clinical Trial Design, Drug Development & Strategic Business Direction With Early Patient Involvement, Insights & Feedback Which Leverage Digital & Technology Innovations Compliantly & Enhance Patient Safety & Journey.

A One-Day Conference & Networking Event, 21st May 2019, The Hallam Conference Centre, Central London

21 Pharma Industry Speakers, Patient Advocacy Groups, Patients & Regulators Tackle The Hurdles To Real Patient Centricity, Embedding Patients Into The Heart Of Business Decision Making Early, Clinical Trials, Technology, Digital Health Device & Drug Development For Tangible Business Results & Better Patient Outcomes & Experiences

  1. Embedding Patients Into The Heart Of Business Decision Making: Tangibly enrich patient and business outcomes by increasing patient centricity and involvement
  2. Improve Clinical Trial Designs With Earlier Patient Involvement: Recruit and action patient feedback early on for more effective R&D and better patient experiences
  3. Patient Perspectives: Patient feedback on what pharma can do to enable more meaningful and effective patient-pharma collaboration
  4. Real-Life Patient-Pharma Collaboration Stories: Overcome internal and external barriers for meaningful, value-adding relationships
  5. Multi-Stakeholder Collaboration: How can multiple stakeholders better align behind the patient for actionable strategies with all-round benefit?
  6. Actioning Patient Feedback: Translate feedback and data into actionable insights and improvements in patient experience, safety and quality of life
  7. Patient Engagement Through Digital & Tech: Leveraging new technologies compliantly for interactive communications which engage patients around their healthcare
  8. Tangible Value-Added: Determining the impact of collaboration to the patient at the bottom line
  9. Patient Safety: Significantly measure to further ensure patient safety throughout the entire patient journey
  10. Overcoming Barriers To Real Patient Centricity: Successfully progressing patient agendas within the organisation

Your Toughest Patient Engagement Challenges In 1 Day: Embedding Patients Into The Heart Of Decision Making • Early Patient Involvement – Clinical Trials • Patient Feedback Board • Patient & Pharma Collaboration • Multiple Stakeholder Collaboration • Data-Led Patient Experiences & Journeys • Patient Engagement Through Digital & Tech •Value-Adding Experiences • Patient Safety • Overcoming Barriers To Patient Centricity

Logo---Banner-2

PLUS! This Patient Centricity & Engagement Conference Also Features:

  • 21 Senior Speakers Take To The Stage In Just 1 Day Including 17 Pharma Brands, 6 Patient Advocacy Group Speakers, NHS & Regulatory Perspectives
  • Collaborative Programme Featuring The Latest Strategies To Enhance Patient Centricity & Engagement & Embed Patients At The Heart Of Decision Making
  • Sister Event Of The Prestigious Digital Pharma Advances & Pharma Social Media Events Series
  • 3 Interactive Q&A Panels On: 'Patient Feedback', 'Key Stakeholder Collaboration' and 'Real-Life Solutions To Patient Centricity Barriers'
  • Breakout Groups By Therapy Area
  • 4 Informal Peer Discussions On: 'Patient Experience', 'Medical Devices', 'Clinical Trials' and 'Engaging HCPs'
  • Open Q&A
  • Senior-Level Networking
  • 2 Conference Chairs
GIC (1GGS)-63
GIC-1GGS-184
GIC-1GGS-150

Secure Better Patient & Business Outcomes With Actionable, Tangible, Value-Adding Strategies To Enhance Patient Centricity & Engagement & Embed Patients At The Heart Of Decision Making

Collaborative Engagement & Experience Strategies Which Inform Clinical Trial Design, Drug Development & Strategic Business Direction With Early Patient Involvement, Insights & Feedback, Leverage Digital & Technology Innovations Compliantly & Enhance Patient Safety & Journey.
A One-Day Conference & Networking Event, 21st May 2019, Central London

08:30 Registration, Morning Coffee & Objective Setting

09:00 GIC Welcome & Morning Chair’s Opening Remarks
Okan Ekinci, Chief Medical Officer, Roche

EMBEDDING PATIENTS AT THE HEART OF DECISION MAKING

09.15 Truly Embedding Patient Centricity Into Decision Making With Meaningful Insights
Bharat Tewarie, EVP & Chief Marketing Officer, UCB

EARLY PATIENT INVOLVEMENT

09.35 Clinical Trial Design & Drug Development: Recruit & Action Patient Feedback On Trial Design For More Effective R&D & Better Patient Outcomes & Experiences

09.35 Perspective One: Marisol Urbieta, Oncology Medical Affairs Head, AstraZeneca

09.55 Perspective Two: David Rich, Vice President, Clinical Development, Rare Diseases, Global R&D, Ipsen

 

THE PATIENT PERSPECTIVE - Q&A PANEL

10.15 The Patient Perspective: What Can Pharma Do To Enable More Meaningful & Effective Patient-Pharma Collaboration?

  • Alison Doyle, Clinical & Operations Director, National Osteoporosis Society

  • Michael Chekroun, CEO and Founder, Carenity
  • Lea-Isabelle Proulx, Patient Insights Leader, Roche

Would you like to become a thought-leader within this debate? If you have any insights to share with our senior-level delegation, please get in touch by emailing partner@patientengagementconference.com or call +44(0)2034792299 today.

10.45 Morning Refreshment Break With Informal Networking

Breakout Groups By Therapy Area:

A: Cancer Care
B: Mental Health
C: Long-Term Conditions
D: Rare Diseases
E: Diabetes
F: Other Breakouts By Area

PATIENT-PHARMA COLLABORATION IN ONCOLOGY – A CASE STUDY

11.15 Our Story: Real-Life Patient-Pharma Collaboration – Overcoming Barriers For Meaningful, Value-Adding Relationships Which Positively Impact Patient Outcomes & Pharma’s Bottom Line

Harriet Doig, Public Policy Manager, MSD Ireland

CASE STUDY

11.35 Leveraging Technology For Optimal Patient Engagement

Peter Gannon, SVP Business Partnerships, Within3

COLLABORATION WITH KEY STAKEHOLDERS - INSIGHTS PANEL

12.05 Exploring Blockers To Multi-Stakeholder Collaboration: How Can We All Align Behind The Patient?

Jill Pearcy, Director, ABPI Code Engagement

Further speakers to be announced. Please check the website for further details.

12.35 Lunch For Speakers, Delegates & Partners

13.05 Informal Peer-To-Peer Discussion Zones

A) Patient Experience: Dr Mate A. Balazs, Country Head - Patient Safety, Novartis

B) Patient Advocacy Group Perspective - Clinical Trials

  • Dr Helen Bulbeck, Director of Services & Policy, Brainstrust - the brain cancer people
  • Stephen Nabarro, Head of Clinical Operations & Data Management, Centre for Drug Discovery, Cancer Research

C) Pharma Perspective - Patient Experience & Clinical Trial Design

  • Lea-Isabelle Proulx, Patient Insights Leader, Roche

D) Engaging HCPs

E) Patient Recruitment

13.35 Afternoon Chair’s Opening Remarks
Paul Edwards, Director of Clinical Services, Dementia UK

ENHANCING PATIENT JOURNEYS, INFORMATION & FEEDBACK - CASE STUDY

13.50 Challenges In Providing Accurate Information To Patients, With An Insight Into Data Use

Speaker to be announced. Please check the website for updates.

PATIENT ENGAGEMENT THROUGH DIGITAL & TECH

14.10 Leveraging New Technologies Compliantly To Improve Patient Experience For Interactive Communications Which Engage Patients Around Their Healthcare

Speakers to be announced. Please check the website for updates.

14.55 Bonus Session Reserved For Exclusive Conference Partner. For more information on how to get involved, please call +44 (0) 20 3479 2299 or email partner@patientengagementconference.com

15.25 Afternoon Refreshment Break With Informal Networking

VALUE-ADDING PATIENT EXPERIENCES

15.50 Determining The Impact Of Patient-Pharma Collaboration & Value Added To The Patient & The Business

Geoff Rollason, Patient Experience & Service Director, Pfizer

PATIENT SAFETY - DOUBLE PERSPECTIVE

16.10 Significant Measures Pharma Can Take To Further Ensure Patient Safety Throughout The Patient Journey

James Whitehead, Principal, Pharmacovigilance Processes & Partnerships, AstraZeneca

Pav Rishiraj, Head of Patient Safety UK & Ireland, Merck

OVERCOMING BARRIERS TO PATIENT CENTRICITY

16.55 It’s All Very Well Talking The Talk But How Can Pharma Actually Take Steps To Progress Their Patient Strategies, Improve Patient Outcomes & Further The Business?

Sara Osborne, Head of Patient Communication & Involvement, Cancer Research

Paul Robinson, European Lead, Patient Innovation, MSD

Isabela Niculae, Associate Director Global Patient Recruitment & Retention Strategist, Biogen

Heather Moses, Head of Medical Affairs Oncology, Roche

17.00 Co-Chairs’ Closing Remarks & Official Close Of Conference

Can you help pharma brands drive patient-centricity and better engage patients? Book an exhibition stand and 2 delegate places for £2,499. Click here to book your stand. Exhibition space is limited and will be issued on a first-come, first-served basis.

For more information on how to get involved, please call +44 (0) 20 3479 2299 or email partner@patientengagementconference.com

exhib-stand
GIC-1GGS-184
GIC-1GGS-150

Press & Media Partners:

If you would like more information on how to become a press and media partner of The Patient Centricity & Engagement Conference, please contact info@patientengagementconference.com